NCT04266301
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04266301
Title Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) (STIMULUS-MDS2)
Acronym STIMULUS-MDS2
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | NLD | LTU | LBN | ITA | ISR | GRC | GBR | FRA | FIN | ESP | DEU | CZE | CHE | CAN | BRA | BEL | AUT | AUS | ARG

Facility Status City State Zip Country Details
Yuma Regional Cancer Center Yuma Arizona 85364 United States Details
University of California LA Los Angeles California 90095 United States Details
Yale University School Of Medicine New Haven Connecticut 06520 United States Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
University Of Miami Miami Florida 33136 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Hackensack University Medical Ctr Hackensack New Jersey 07601 United States Details
Weill Cornell Medicine NY-Presb New York New York 10021 United States Details
University of Rochester Medical Ctr Rochester New York 14642 United States Details
University of Virginia Charlottesville Virginia 22903 United States Details
Novartis Investigative Site Pilar Buenos Aires B1629AHJ Argentina Details
Novartis Investigative Site Wooloongabba Queensland 4102 Australia Details
Novartis Investigative Site Clayton Victoria 3168 Australia Details
Novartis Investigative Site Perth Western Australia 6000 Australia Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Linz 4020 Austria Details
Novartis Investigative Site Roeselare West-Vlaanderen 8800 Belgium Details
Novartis Investigative Site Brasschaat 2930 Belgium Details
Novartis Investigative Site Florianópolis Santa Catarina 88020-210 Brazil Details
Novartis Investigative Site São Paulo São Paulo 04014-002 Brazil Details
Novartis Investigative Site São Paulo São Paulo 05319-000 Brazil Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Viña del Mar Región de Valparaíso 2540364 Chile Details
Novartis Investigative Site Guangzhou Guangdong 510080 China Details
Novartis Investigative Site Guangzhou Guangdong 510515 China Details
Novartis Investigative Site Shenzhen Guangdong 518037 China Details
Novartis Investigative Site Wuhan Hubei 430022 China Details
Novartis Investigative Site Wuhan Hubei 430030 China Details
Novartis Investigative Site Suzhou Jiangsu 215004 China Details
Novartis Investigative Site Changchun Jilin 130021 China Details
Novartis Investigative Site Chengdu Sichuan 610041 China Details
Novartis Investigative Site Hangzhou Zhejiang 310003 China Details
Novartis Investigative Site Beijing 100029 China Details
Novartis Investigative Site Beijing 100730 China Details
Novartis Investigative Site Jinan 250012 China Details
Novartis Investigative Site Shanghai 200025 China Details
Novartis Investigative Site Shanghai 200233 China Details
Novartis Investigative Site Tianjin 300020 China Details
Novartis Investigative Site Tianjin 300052 China Details
Novartis Investigative Site Rionegro Antioquia 054047 Colombia Details
Novartis Investigative Site Bogotá 110231 Colombia Details
Novartis Investigative Site Brno 625 00 Czechia Details
Novartis Investigative Site Hradec Králové 500 05 Czechia Details
Novartis Investigative Site Prague 128 00 Czechia Details
Novartis Investigative Site Prague 128 08 Czechia Details
Novartis Investigative Site Helsinki FIN 00290 Finland Details
Novartis Investigative Site Kuopio 70211 Finland Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Tours 37044 France Details
Novartis Investigative Site Vandœuvre-lès-Nancy 54511 France Details
Novartis Investigative Site Frankfurt am Main Hesse 60590 Germany Details
Novartis Investigative Site Velbert North Rhine-Westphalia 42551 Germany Details
Novartis Investigative Site Dresden Saxony 01307 Germany Details
Novartis Investigative Site Jena Thuringia 07740 Germany Details
Novartis Investigative Site Augsburg 86179 Germany Details
Novartis Investigative Site Düsseldorf 40479 Germany Details
Novartis Investigative Site Greifswald 17475 Germany Details
Novartis Investigative Site Kiel 24116 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Alexandroupoli 681 00 Greece Details
Novartis Investigative Site Pátrai 265 04 Greece Details
Novartis Investigative Site Ahmedabad Gujarat 380009 India Details
Novartis Investigative Site Faridabad Haryana 121 001 India Details
Novartis Investigative Site Madurai Tamil Nadu 625107 India Details
Novartis Investigative Site Kolkata West Bengal 700014 India Details
Novartis Investigative Site Kolkata West Bengal 700160 India Details
Novartis Investigative Site Delhi 110085 India Details
Novartis Investigative Site Afula 1834111 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Catania CT 95123 Italy Details
Novartis Investigative Site Florence FI 50134 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milan MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Roma RM 00133 Italy Details
Novartis Investigative Site Nagoya Aichi-ken 464 8681 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Fukuoka Fukuoka 812-8582 Japan Details
Novartis Investigative Site Sapporo Hokkaido 064 0804 Japan Details
Novartis Investigative Site Isehara Kanagawa 259-1193 Japan Details
Novartis Investigative Site Sendai Miyagi 980 8574 Japan Details
Novartis Investigative Site Nagasaki Nagasaki 852-8501 Japan Details
Novartis Investigative Site Sakai Osaka 590-0197 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8603 Japan Details
Novartis Investigative Site Yamagata Yamagata 990 9585 Japan Details
Novartis Investigative Site Osaka 545-8586 Japan Details
Novartis Investigative Site Beirut 113-0236 Lebanon Details
Novartis Investigative Site Vilnius LT-08406 Lithuania Details
Novartis Investigative Site George Town Pulau Pinang 10450 Malaysia Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Kuala Selangor 68000 Malaysia Details
Novartis Investigative Site Satélite Edo Mexico 53100 Mexico Details
Novartis Investigative Site Mexico City Mexico City 06720 Mexico Details
Novartis Investigative Site Morelia Michoacán 58260 Mexico Details
Novartis Investigative Site Estado de México 52787 Mexico Details
Novartis Investigative Site Groningen Provincie Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Khoudh 123 Oman Details
Novartis Investigative Site Lisbon 1099-023 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Saint Petersburg 191024 Russia Details
Novartis Investigative Site Saint Petersburg 197022 Russia Details
Novartis Investigative Site Riyadh 11211 Saudi Arabia Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Seoul Korea 03080 South Korea Details
Novartis Investigative Site Seoul Seoul 06351 South Korea Details
Novartis Investigative Site Seoul 03722 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Seoul 06591 South Korea Details
Novartis Investigative Site Badalona Barcelona 08916 Spain Details
Novartis Investigative Site Salamanca Castille and León 37007 Spain Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site Oviedo Principality of Asturias 33011 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Seville 41013 Spain Details
Novartis Investigative Site Valencia 46010 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Bern 3010 Switzerland Details
Novartis Investigative Site Zurich 8091 Switzerland Details
Novartis Investigative Site Hualien City 970 Taiwan Details
Novartis Investigative Site Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site Liouying Township 736005 Taiwan Details
Novartis Investigative Site Taichung 40447 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taoyuan District 33305 Taiwan Details
Novartis Investigative Site Songkhla Hat Yai 90110 Thailand Details
Novartis Investigative Site Khon Kaen THA 40002 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10400 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Chiang Mai 50200 Thailand Details
Novartis Investigative Site Samsun Atakum 55200 Turkey (Türkiye) Details
Novartis Investigative Site Edirne Merkez 22030 Turkey (Türkiye) Details
Novartis Investigative Site Istanbul Pendik 34899 Turkey (Türkiye) Details
Novartis Investigative Site Ankara 06230 Turkey (Türkiye) Details
Novartis Investigative Site Izmir 35100 Turkey (Türkiye) Details
Novartis Investigative Site Portsmouth Hants PO6 3LY United Kingdom Details
Novartis Investigative Site Edinburgh Scotland EH4 2XU United Kingdom Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
Novartis Investigative Site Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field